Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1, open label study to assess the safety and tolerability of U3 1565,
determine maximum tolerated dose (MTD) or establish maximum administered dose (MAD) safety
and tolerability.